Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
64 Cards in this Set
- Front
- Back
what is RDS
|
Respiratory Distress Syndrome, seen in premature infants with no surfactant
|
|
RDS aka...
|
Hyaline membrane disease (HMD)
|
|
Predict RDS/HMD by testing ____ _______.
|
amniotic fluid ("cascade testing"; florescence polarization study)
|
|
RDS treatment
|
corticosteroids (before birth), exogenous surfactant (aerosolized, sprayed into lungs)
|
|
RDS complication: Repeated collapse of alveoli leads to trauma which ultimately leads to...
|
fibrin-rich exudate leaking into alveolus causin hyaline membranes (and thick alveolar walls)
|
|
Other complications of RDS (3)
|
- blindness (Stevie Wonder; oxygen toxicity, retina problems)
- bronchopulmonary dysplasia (rare now; oxygen toxicity but ventilation is better now) - risk of cerebral intravascular hemorrhage (very premature babies) |
|
adenomatoid malformation (describe)
|
cystic hamartoma of the lung: lobe of the lung grows as a misshapen cyst.
|
|
Most common mutation in cystic fibrosis (CF)
|
delta-F-508
|
|
gene effected in CF
|
CFTR (cystic fibrosis transmembrane regulator)
|
|
Most common lethal mutation in caucasians
|
delta-F-508 (disease = CF)
|
|
CF causes continual infection, dilating the bronchi, termed, "______."
|
bronchiectasis
|
|
transudate and exudate share this common characteristic by definition
|
fluid in an inappropriate place
|
|
transudate vs. exudate
|
Transudate = LOW protein content
Exudate = HIGH protein content . . . "EXtra protein" (causes hyaline membranes allowing protein deposition) |
|
Kerley B lines indicate
|
pulmonary edema
|
|
Causes of pulmonary edema (2)
|
- Left sided heart failure (increased pulmonary pressure)
- toxic injury leading to increased capillary permeability (risk of ARDS from fibrin leakage) |
|
4 steps of acid-base analysis
|
1 - pH (high/low)
2 - Metabolic/Respiratory 3 - Anion Gap 4 - Appropriate and Effective Compensation? |
|
Alkalemia if pH is greater than
|
7.44
|
|
Acidemia if pH is less than
|
7.36
|
|
RESPIRATORY alkalemia if PaCO2 is less than
|
36 mmHg (around there...this is according to Dr. Simpson)
|
|
METABOLIC alkalemia if HCO3 is greater than
|
27 meq/L (around there...this is according to Dr. Simpson)
|
|
RESPIRATORY acidemia if PaCO2 is greater than
|
40 mmHg (around there...this is according to Dr. Simpson)
|
|
METABOLIC acidemia if HCO3 is less than
|
24 meq/L (around there...this is according to Dr. Simpson)
|
|
Formula for calculating the anion gap
|
Anion Gap = Na - (Cl + HCO3)
i.e. Anion Gap = Sodium - (Chloride + Bicarbonate) |
|
Normal anion gap value
|
less than 12
|
|
Mnemonic for causes of Anion Gap elevation
|
KUSSMALE: ketoacidosis (diabetic and EtOH related), uremia, salicylates, starvation, methanol, aldehydes, lactate, ethylene glycol (antifreeze)
|
|
If compensation is at work, how should PaCO2 and HCO3 values be shifted?
|
They will be shifted in the SAME direction (both elevated/decreased)
|
|
"Normal" PaCO2 value on ABG (according to Dr. Simpson)
|
36 mmHg (around there...this is according to Dr. Simpson)
|
|
"Normal" HCO3 value on ABG (according to Dr. Simpson)
|
24 meq/L (around there...this is according to Dr. Simpson)
|
|
METABOLIC acidosis: Equation to estimate change in PaCO2 value during compensation.
|
delta-PaCO2 = 1.3(delta-HCO3)
Hint: Think the HIGHER number (1.3) goes with an abnormally low HCO3 value because we want it to be HIGHER. Note: please remember that "delta" represents "change in..." (It looks like a triangle) |
|
METABOLIC alkalosis: Equation to estimate change in PaCO2 value during compensation
|
delta-PaCO2 = 0.6(delta-HCO3)
Hint: Thing the LOWER number (0.6) goes with an abnormally high HCO3 value because we want it to be LOWER. Note: please remember that "delta" represents "change in..." (It looks like a triangle) |
|
RESPIRATORY acidosis: Equation to estimate change in HCO3 value during compensation in an ACUTE setting.
|
delta-HCO3 = .1(delta-PaCO2)
or delta-HCO3 = .2(delta-PaCO2) Hint: Same as alkalosis. "Small" numbers (.1, .2) go with "short" and "acute." |
|
RESPIRATORY acidosis: Equation to estimate change in HCO3 value during compensation in an CHRONIC setting.
|
delta-HCO3 = .4(delta-PaCO2)
or delta-HCO3 = .5(delta-PaCO2) Hint: Same as alkalosis. "Big" numbers (.4, .5) go with "long" and "chronic." |
|
RESPIRATORY alklalosis: Equation to estimate change in HCO3 value during compensation in an ACUTE setting.
|
delta-HCO3 = .1(delta-PaCO2)
or delta-HCO3 = .2(delta-PaCO2) Hint: Same as acidosis. "Small" numbers (.1, .2) go with "short" and "acute." |
|
RESPIRATORY alklalosis: Equation to estimate change in HCO3 value during compensation in an CHRONIC setting.
|
delta-HCO3 = .3(delta-PaCO2)
or delta-HCO3 = .4(delta-PaCO2) Hint: Same as alkalosis. "Big" numbers (.3, .4) go with "long" and "chronic." |
|
If a patient is compensating as expected for an acidosis/alkalosis, but the pH is STILL off, what does this mean?
|
There are at least 2 processes at work.
|
|
3 possible causes of an acidosis with a normal anion gap ("hyperchloremic acidosis")
|
- Kidney
- Bowel - Resuscitation w/ normal saline |
|
Oxygen "carrying capacity" of blood
|
Focuses on hemoglobin: 1.36mL/g multiplied by grams of Hb...
|
|
Oxygen "content"
|
((O2 bound to Hb)(% saturation)) + dissolved O2 in plasma
|
|
Direction of shift in Hb-dissociation curve indicating a higher affinity
|
Left shift of the Hb-dissociation curve
|
|
Direction of teh shift in the Hb-dissociation cure indicating a lower affinity
|
Right shift of the Hb-dissociation curve
|
|
Four things which cause a right-shift of the Hb-dissociation curve
|
- Increased [H+] (lower pH)
- Increased temperature - Increased [DPG] - Increased PCO2 |
|
Most CO2 carried through the bloodstream via _______
|
- bicarbonate (80-90%)
- carbamino Hb (7%) - dissolved (4%) |
|
Define stagnant hypoxia
|
normal PaCO2; low PvO2 (lower than normal venous oxygen). Cuased by slow peripheral blood flow (heart failure, shock, local obstruction)
|
|
define hypoxic hypoxia
|
low PaCO2 (low arterial oxygen). Caused by all the classic lung problems - interstitial disease, V/Q mismatch, COPD, high altitude, etc
|
|
define histoxic hypoxia
|
can't utilize oxygen. Cause by cyanide poisioning (blocks the electron transport chain).
|
|
define anemic anoxia
|
reduced functional hemoglobin. Caused by anemia, and CO poisioning.
|
|
Describe the three pulmonary mechanoreceptors
|
- stretch: in smooth muscle layers of airways. They terminate inspiration/expiration.
- irritant: between epithelial airway lining. Sensitive to smoke, cold air, dust, etc. (Plays a role in asthma bronchoconstriction?) - J: "juxta-capillary." close to capillaries. can cause rapid shallow breathing and dyspnea. |
|
T or F: CF is autosomal recessive
|
true
|
|
on which chromosome is the CFTR gene?
Bonus points: long arm or short arm? |
7, long arm ("q" arm...b/c it's the next letter after "p" which stands for "petite" which is for the short arm.)
|
|
Reproductive anomalies seen in CF
|
- bilateral absence of vas deferens
- decreased ability of ova transit through fallopian tubes |
|
Kidney anomalies seen in CF
|
- INCREASED ability to clear beta lactam antibiotics
|
|
Sinus anomaly seen in CF
|
severe chronic sinusitis
|
|
Mechanistic pathway of pathology in CF
|
1 - CF mutation
2 - thick mucus 3 - infection 4 - inflammation 5 - tissue destruction/bronchiectasis |
|
CF mutation can also lead to malabsorption/malnutrition. Which organ's fault is this and how to treat?
|
Pancreas, first discovered that you can treat with ground-up pancreases from slaughtered livestock!
|
|
Describe targeted CF treatment(s): Targeting the CF Gene and CFTR protein itself
|
CF Gene:
• VX-770: drug that opens the Cl channels; however, it's so targeted at a specific genotype, it will only work with 2% of CF patients. |
|
Describe targeted CF treatment(s): Targeting the mucus itself and airway obstruction.
|
Airway Obstruction (thick mucus):
• CPT/Airway Clearance: Pounding on chest and patient coughing. (CPT = chest physical therapy) • rhDNase: discovered in the 60s that it's DNA that makes the thick secretions so goopy and sticky. Using animal rhDNase had miraculous effects until severe allergic rxns a couple weeks later. After recombinant human insulin started getting mnfctd, they tried it with human rhDNase, but not quite as miraculous effect. • Hypertonic saline: based on the observation in Australia that CF patients who enjoyed surfing had better clinical outcomes. • Albuterol: It helps everyone a bit. |
|
Describe targeted CF treatment options: Targeting infection.
|
Infection:
• CPT/Airway Clearence: it also physically removes the bacteria, but keep in mind that there's naturally lots of bacteria in the lungs. • Antibiotics: They help. Watch out for bigger and badder bacteria as we kill off the weaker ones. • Vaccines: They help. |
|
Describe targeted CF treatment options: Targeting inflammation (the cause of lung destruction)
|
Inflammation (key point of disease -- the cause of lung destruction):
• Steroids: helps with inflammation. Obviously. Mixed bag as well (just like ibuprofen) because you have to deal with all the side effects. • Azithromycin: Also convenient that it's also anti-pseudomonas. • Ibuprofen: MDs scared of the bleeding and other complications. |
|
Describe targeted CF treatment options: Treating actual tissue destruction
|
Tissue Destruction:
• Lung Transplant: After all the other options, this is the very last one. $480,000 after transplant and care for first year. $80,000 for medications (per year?) |
|
Three steps to diagnose CF
|
1 - Clinical syndrome
2 - Laboratory demonstration of CFTR defect (either abnormal sweat chloride test, or nasal potential difference) 3 - ID genetic mutation Note with #2, there are other supportive - but not definitive - tests for CF diagnosis such as CXR, CT, PFTs, and stool studies. |
|
Common predisposing factor to pulmonary emboli
|
deep vein thrombosis
|
|
Common clinical presentation for PRIMARY (more rare) pulmonary hypertension
|
dyspnea, 20-40 y/o female; caused by BMPR2 mutation
|
|
describe Goodpasture's syndrome
|
anti-glomerular basement membrane antibody; glomerulonephritis, and pulmonary hemorrhage.
|
|
describe Wegener's Granulomatosis
|
necrotizing granulomas and vasculitis; c-ANCA positive; renal and upper airway disease too
|